Portfolio company
Adient
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops absorbable vascular filters for patients at risk of pulmonary embolism to eliminate surgical removal procedures and long-term complications.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Append Medical
The company develops a transcatheter system for left atrial appendage elimination to prevent strokes in patients with atrial fibrillation without leaving permanent metal implants.
Aquesys
This company develops and manufactures ocular implants for glaucoma patients to reduce intraocular pressure through minimally invasive surgical procedures.
Ardian
This company develops medical devices for catheter-based renal denervation to treat hypertension in patients with high blood pressure.
Endovascular Engineering, Inc.
The company develops a mechanical thrombectomy platform for physicians to remove blood clots in patients with venous thromboembolism and pulmonary embolism.
THROMBECTOMY SYSTEMS
This company develops catheter-based clot removal systems for physicians treating patients with venous thromboembolism, deep vein thrombosis and pulmonary embolism.
Penditure
This company produces implantable clips for left atrial appendage exclusion to reduce stroke risk in patients undergoing cardiac surgery.
Intelvasc
This company develops implantable sensors and monitoring systems to track blood flow and vascular occlusions for patients with peripheral arterial disease.
Claret Medical
This company develops cerebral embolic protection systems that capture and remove debris during cardiovascular procedures for hospitals and heart surgeons.
